180 related articles for article (PubMed ID: 10535443)
1. Targeting autoimmune diabetes with gene therapy.
Giannoukakis N; Rudert WA; Robbins PD; Trucco M
Diabetes; 1999 Nov; 48(11):2107-21. PubMed ID: 10535443
[TBL] [Abstract][Full Text] [Related]
2. Approaches for the cure of type 1 diabetes by cellular and gene therapy.
Jun HS; Yoon JW
Curr Gene Ther; 2005 Apr; 5(2):249-62. PubMed ID: 15853732
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
[TBL] [Abstract][Full Text] [Related]
4. Adeno-associated virus vector mediated gene transfer to pancreatic beta cells.
Prasad KM; Yang Z; Bleich D; Nadler JL
Gene Ther; 2000 Sep; 7(18):1553-61. PubMed ID: 11021593
[TBL] [Abstract][Full Text] [Related]
5. Pathology of an islet transplant 2 years after transplantation: evidence for a nonimmunological loss.
Smith RN; Kent SC; Nagle J; Selig M; Iafrate AJ; Najafian N; Hafler DA; Auchincloss H; Orban T; Cagliero E
Transplantation; 2008 Jul; 86(1):54-62. PubMed ID: 18622278
[TBL] [Abstract][Full Text] [Related]
6. Potential role of TRAIL in the management of autoimmune diabetes mellitus.
Bernardi S; Norcio A; Toffoli B; Zauli G; Secchiero P
Curr Pharm Des; 2012; 18(35):5759-65. PubMed ID: 22726118
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in insulin gene therapy for type 1 diabetes.
Yoon JW; Jun HS
Trends Mol Med; 2002 Feb; 8(2):62-8. PubMed ID: 11815271
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-mediated TRAIL gene (Ad5hTRAIL) delivery into pancreatic islets prolongs normoglycemia in streptozotocin-induced diabetic rats.
Dirice E; Sanlioglu AD; Kahraman S; Ozturk S; Balci MK; Omer A; Griffith TS; Sanlioglu S
Hum Gene Ther; 2009 Oct; 20(10):1177-89. PubMed ID: 19572802
[TBL] [Abstract][Full Text] [Related]
9. Diabetic nephropathy and beta-cell replacement therapy.
de Fijter JW
Neth J Med; 2004 Mar; 62(3):71-5. PubMed ID: 15209470
[TBL] [Abstract][Full Text] [Related]
10. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells.
Suri A; Calderon B; Esparza TJ; Frederick K; Bittner P; Unanue ER
Science; 2006 Mar; 311(5768):1778-80. PubMed ID: 16556846
[TBL] [Abstract][Full Text] [Related]
11. Efficient gene delivery to human and rodent islets with double-stranded (ds) AAV-based vectors.
Rehman KK; Wang Z; Bottino R; Balamurugan AN; Trucco M; Li J; Xiao X; Robbins PD
Gene Ther; 2005 Sep; 12(17):1313-23. PubMed ID: 15858610
[TBL] [Abstract][Full Text] [Related]
12. Hepatic insulin gene therapy in insulin-dependent diabetes mellitus.
Nett PC; Sollinger HW; Alam T
Am J Transplant; 2003 Oct; 3(10):1197-203. PubMed ID: 14510692
[TBL] [Abstract][Full Text] [Related]
13. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
[TBL] [Abstract][Full Text] [Related]
14. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
Fändrich F; Ungefroren H
Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy in diabetes mellitus: promises and piffalls.
Welsh N
Curr Opin Mol Ther; 1999 Aug; 1(4):464-70. PubMed ID: 11713761
[TBL] [Abstract][Full Text] [Related]
16. Gene and cell therapies for diabetes mellitus: strategies and clinical potential.
Giannoukakis N; Robbins PD
BioDrugs; 2002; 16(3):149-73. PubMed ID: 12102644
[TBL] [Abstract][Full Text] [Related]
17. Toward cell-based therapy of type I diabetes.
Kabelitz D; Geissler EK; Soria B; Schroeder IS; Fändrich F; Chatenoud L
Trends Immunol; 2008 Feb; 29(2):68-74. PubMed ID: 18182324
[TBL] [Abstract][Full Text] [Related]
18. In vivo gene transfer to pancreatic beta cells by systemic delivery of adenoviral vectors.
Ayuso E; Chillón M; Agudo J; Haurigot V; Bosch A; Carretero A; Otaegui PJ; Bosch F
Hum Gene Ther; 2004 Aug; 15(8):805-12. PubMed ID: 15319037
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for diabetes mellitus.
Yamaoka T
Curr Mol Med; 2001 Jul; 1(3):325-37. PubMed ID: 11899081
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy for diabetes.
Demeterco C; Levine F
Front Biosci; 2001 Feb; 6():D175-91. PubMed ID: 11171547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
